Approval · Notice of Compliance 35826 · 2025
MIEBO: Notice of Compliance 35826
Issued August 12, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35826
- Date
- August 12, 2025
- Company
- Bausch & Lomb Inc.Rochester, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of a primary container closure system
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIEBO | Not yet assigned | — |
Medicinal ingredients
- PERFLUOROHEXYLOCTANE 100 PER